Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other ... Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.47 | 10.3296703297 | 4.55 | 5.55 | 4.42 | 754037 | 5.13016397 | CS |
| 4 | -1.38 | -21.5625 | 6.4 | 8.2457 | 4.31 | 2675433 | 6.40769818 | CS |
| 12 | -1.28 | -20.3174603175 | 6.3 | 11 | 4.31 | 3248032 | 6.52326256 | CS |
| 26 | -1.491 | -22.8997081861 | 6.511 | 11 | 4.31 | 2052101 | 6.34035106 | CS |
| 52 | 0.22 | 4.58333333333 | 4.8 | 11 | 2.02 | 2007159 | 5.44134033 | CS |
| 156 | -3.88 | -43.595505618 | 8.9 | 28.7 | 2.02 | 1431772 | 10.58808133 | CS |
| 260 | -80.48 | -94.1286549708 | 85.5 | 87.3 | 2.02 | 1160869 | 12.35839209 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
